30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jack Henneman

Track

Insider profile

Currently holds positions in SeaSpine Holdings Corp and R1 RCM Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director SeaSpine Holdings Corp July 1, 2015 -
Independent Director R1 RCM Inc Jan. 1, 2017 -
Chief Administrative Officer, Secretary Lumos Pharma Inc July 26, 2018 - Nov. 9, 2018
Chief Financial Officer, Secretary Lumos Pharma Inc Dec. 22, 2014 - July 26, 2018
Director R1 RCM Inc Feb. 16, 2016 - Jan. 1, 2017
Chief Financial Officer, Executive Vice President Lumos Pharma Inc Oct. 1, 2014 - Dec. 22, 2014
Chief Administrative Officer, Corporate Vice President Integra Lifesciences Holdings Corp May 2, 2014 - Sept. 30, 2014
Corporate Vice President - Finance and Administration, Chief Financial Officer Integra Lifesciences Holdings Corp Dec. 1, 2012 - May 2, 2014
Chief Financial Officer, Executive Vice President Integra Lifesciences Holdings Corp May 13, 2008 - Dec. 1, 2012
Jack Henneman's trades of Orthofix Medical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-08 2026-05-07
B Purchase
27,912 +49.2%
270.39
US$659,878 		27,912 +49.2% 270.39 US$659,878
2026-05-04 2026-05-01
B Purchase
14,185 -36.6%
314.54
US$502,088 		14,185 -36.6% 314.54 US$502,088
2024-03-14 2024-03-13
B Purchase
24,651 -41.5%
362.39
US$3,038,281 		24,651 -41.5% 362.39 US$3,038,281
2023-08-09 2023-08-08
S Sale
50,000 -40.9%
17.17
US$858,650 		50,000 -40.9% 17.17 US$858,650
2023-08-08 2023-08-08
PrS Proposed sale
50,000
17.17
US$858,635 		50,000 17.17 US$858,635
2021-05-20 2021-05-18
B Purchase
2,000 +21.5%
42.86
US$85,720 		2,000 +21.5% 42.86 US$85,720
2020-08-05 2020-08-05
PlS Planned sale
10,000 -14.2%
15.00
US$150,000 		10,000 -14.2% 15.00 US$150,000
2019-10-07 2019-10-07
B Purchase
5,000 +inf%
15.00
US$75,000 		5,000 +inf% 15.00 US$75,000
2004-07-14 2004-07-12
S Sale
6,000 -100.0%
33.50
US$201,008 		6,000 -100.0% 33.50 US$201,008
2004-05-12 2004-05-10
S Sale
6,000 -16.5%
30.68
US$184,090 		6,000 -16.5% 30.68 US$184,090